Previous close | 56.61 |
Open | N/A |
Bid | 0.00 |
Ask | 0.00 |
Strike | 110.00 |
Expiry date | 2026-12-18 |
Day's range | 56.61 - 56.61 |
Contract range | N/A |
Volume | |
Open interest | N/A |
The FDA approved Moderna's RSV vaccine, allowing the biotech to launch its second-ever product. But Moderna stock retreated.
Moderna stock is on the rise again as investors focus on the potential need for a bird flu vaccine. Is MRNA stock a buy right now?
Moderna stock seesawed Thursday after confirming the U.S. government is nearing a deal to fund its pandemic bird flu vaccine.